FDA OKs First Immunotherapy Combo Regimen for Breast Cancer – Pharmacy Times

Posted by on March 11, 2019 5:47 pm
Tags:
Categories: Crispr Articles

Source: FDA OKs First Immunotherapy Combo Regimen for Breast Cancer – Pharmacy Times

[unable to retrieve full-text content]

FDA OKs First Immunotherapy Combo Regimen for Breast Cancer  Pharmacy Times

With this approval, atezolizumab plus nab-paclitaxel is the first cancer immunotherapy regimen to be approved for breast cancer.

Published at Fri, 08 Mar 2019 21:30:59 +0000

< Immunotherapy Today home